The Eshelman Institute for Innovation recently opened its pre-proposal application for the 2022 annual grant cycle. The Institute seeks to fund translational research related to therapeutics focused on oncology, infectious disease, and neuroscience, including rare diseases, and all digital health technologies. The Institute also welcomes ideas for devices and diagnostics, and other therapeutic areas and services.

The Eshelman Institute for Innovation recently opened its pre-proposal application for the 2022 annual grant cycle. All faculty and staff at UNC-Chapel Hill are eligible to apply. All applicants are required to submit a pre-proposal as the first step in the application process and pre-proposals are due Jan. 6, 2022.
More Information and a link to the pre-proposal form can be found on the Eshelman Institute for Innovation website.
The Eshelman Institute seeks to fund translational research related to therapeutics focused on oncology, infectious disease, and neuroscience, including rare diseases, and all digital health technologies. The Institute also welcomes ideas for devices and diagnostics as well as other therapeutic areas and services.
The Eshelman Institute aims to increase the diversity of translational projects in therapeutics and digital health and to stimulate cross-unit collaboration to deliver even more value for the University. In addition, the Institute strongly encourages collaboration with its HBCU partners at Meharry Medical College and North Carolina Agricultural and Technical State University. If you are interested in working with the Institute’s HBCU partners, please contact the Institute for more information.
To learn more about the Institute’s grant process and to view all questions outlined in the pre-proposal, view the grant guidelines on the Institute’s website. Additional questions can be sent to eshelmaninstitute@unc.edu.